A Novel Compound ARN-3236 Inhibits Salt-Inducible Kinase 2 and Sensitizes Ovarian Cancer Cell Lines and Xenografts to PaclitaxelJinhua Zhou, Robert C. Bast, Shu Zhang et al.|Clinical Cancer Research|2016Cited by 77